Cancer Stem Cells: Why Cancer Comes Back — And What Actually Works Against Them

By Dr. Yahia Anane, PhD

If you’ve ever wondered why cancer can return months or even years after “successful” treatment — this is the answer.

The reason is a small, hidden group of cells inside every tumor called cancer stem cells, or CSCs. Understanding them changes everything about how you fight cancer.


What Are Cancer Stem Cells?

Inside every tumor, there is a tiny population of cells — sometimes as few as 1 in 100 — that are completely different from the rest.

They are not the bulk of the tumor. They are the root of it.

The root of recurrence. The root of spread. The root of metastasis.

Chemotherapy, radiation, and surgery are very good at killing the bulk of the tumor — the cells you see shrinking on a scan. But these treatments often cannot touch the cancer stem cells.

And this is why cancer comes back.


What Makes Them So Hard to Kill

Cancer stem cells have four built-in survival tricks that make them nearly invisible to standard treatment:

1. They copy themselves forever

A single cancer stem cell can rebuild the entire tumor from scratch after treatment ends. This is called self-renewal. It is the main reason tumors come back, often in new places.

📄 Chang JC. Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance. Medicine, 2016. 🔗 https://pubmed.ncbi.nlm.nih.gov/27611935/

2. They pump chemo back out

Cancer stem cells have tiny pumps on their surface called ABC transporters. When chemotherapy enters the cell, these pumps push the drug straight back out — before it can do any damage.

📄 Dean M. ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology and Neoplasia, 2009. 🔗 https://pubmed.ncbi.nlm.nih.gov/19224345/

3. They go to sleep during treatment

When chemo or radiation starts, cancer stem cells enter a dormant state called quiescence. They stop dividing completely. Since most cancer treatments only kill dividing cells, the sleeping ones survive untouched.

When treatment stops, they wake up — and rebuild.

📄 De Angelis ML et al. Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance. Frontiers in Oncology, 2019. 🔗 https://pubmed.ncbi.nlm.nih.gov/31355143/

4. They block their own death signals

Healthy cells have a built-in self-destruct system called apoptosis. Cancer stem cells overproduce a protein called BCL-2 that blocks this system. They simply refuse to die.

📄 Phi LTH et al. Cancer Stem Cells in Drug Resistance. Stem Cells International, 2018. 🔗 https://pubmed.ncbi.nlm.nih.gov/29681949/


What Actually Works Against Them

Cancer stem cells are kept alive by three main signaling pathways: Wnt/β-catenin, Notch, and Hedgehog.

The good news: several inexpensive, well-studied tools in metabolic therapy target these pathways directly. Within the TMT protocol:

  • Ivermectin — blocks the Wnt/β-catenin pathway, one of the main “stay alive” signals for cancer stem cells
  • Fenbendazole — disrupts how CSCs divide and how they take in glucose
  • Curcumin — lowers BCL-2, restoring the cell’s ability to die
  • Black seed oil (thymoquinone) — suppresses survival signaling
  • Itraconazole — blocks the Hedgehog pathway, another major CSC lifeline
  • Ketogenic diet and fasting — starve CSCs of the glucose and IGF-1 growth signals they depend on

These tools work together. No single one is enough. But used in combination, they put pressure on cancer stem cells from many directions at once — exactly what is needed to weaken them.


Why This Matters for You

If your treatment plan only targets the bulk of the tumor, you may shrink the cancer — but you leave the root behind.

Real long-term control means going after the cancer stem cells too. That means:

  • Lowering the fuel they live on (glucose, insulin, IGF-1)
  • Blocking their survival pathways (Wnt, Notch, Hedgehog)
  • Breaking down their resistance to cell death (BCL-2)
  • Waking them up and exposing them to immune attack

This is why metabolic therapy is not “alternative” or “extra.” It targets the part of cancer that conventional treatment misses — the part that decides whether cancer comes back.


The Bottom Line

Cancer stem cells are a small fraction of the tumor — but the most dangerous fraction.

They survive through:

  • Pumps that throw out chemo
  • Sleep mode during treatment
  • Strong DNA repair
  • Built-in resistance to cell death

Killing the bulk of the tumor is not enough. Targeting the root is essential.

This is the difference between treating cancer and actually finishing it.


This article is for education only and does not replace medical advice. Always work with a qualified healthcare professional when making treatment decisions.

Dr. Yahia Anane, PhD — drananeyahia.com